{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:16:11Z","timestamp":1792977371182,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL094301-09"],"award-info":[{"award-number":["5T32HL094301-09"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01 HC45207"],"award-info":[{"award-number":["N01 HC45207"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jchf.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T15:55:38Z","timestamp":1599666938000},"page":"1009-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Associations Between Depressive Symptoms and HFpEF-Related Outcomes"],"prefix":"10.1016","volume":"8","author":[{"given":"Alvin","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.D.","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Heitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2020.06.010_bib1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in heart failure. a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1089\/jwh.2014.4919","article-title":"Depression and its comorbid conditions more serious in women than in men in the United States","volume":"24","author":"Kim","year":"2015","journal-title":"J\u00a0Women\u2019s Health"},{"key":"10.1016\/j.jchf.2020.06.010_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2003.07.013","article-title":"Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure","volume":"42","author":"Rumsfeld","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejim.2013.01.003","article-title":"Determinants of change in quality of life in the\u00a0Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD)","volume":"24","author":"Scherer","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jchf.2020.06.010_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction: The Aldo-DHF Randomized Controlled Trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.06.010_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline against depression and heart disease in chronic heart failure) trial","volume":"56","author":"O\u2019Connor","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib7","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.2016.7635","article-title":"Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression","volume":"315","author":"Angermann","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.06.010_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCHEARTFAILURE.114.001838","article-title":"Baseline distribution of participants with depression and impaired quality of life in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"8","author":"Hamo","year":"2015","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib9","first-page":"23","article-title":"Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction","volume":"60","author":"Kato","year":"2012","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib10","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejheart.2006.10.012","article-title":"Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM","volume":"9","author":"Lewis","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2020.06.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.114.001937","article-title":"Impact of spironolactone on longitudinal changes in health-related quality of life in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"9","author":"Lewis","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the Treatment of Preserved Cardiac Function Heart\u00a0Failure with an Aldosterone Antagonist Trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2020.06.010_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jchf.2020.06.010_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCHEARTFAILURE.112.000118","article-title":"Depression, healthcare utilization, and death in heart failure: a community study","volume":"6","author":"Moraska","year":"2013","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.jchf.2020.06.010_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1474515112468068","article-title":"Psychometrics of the PHQ-9 as a measure of depressive symptoms in patients with heart failure","volume":"12","author":"Hammash","year":"2013","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jchf.2020.06.010_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","article-title":"Monitoring depression treatment outcomes with the patient health questionnaire-9","volume":"42","author":"L\u00f6we","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.jchf.2020.06.010_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jad.2010.04.030","article-title":"Defining successful treatment outcome in depression using the PHQ-9: a comparison of methods","volume":"127","author":"McMillan","year":"2010","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jchf.2020.06.010_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2004.09.034","article-title":"Predictors of the onset of depressive symptoms in patients with heart failure","volume":"44","author":"Havranek","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjcard.2010.10.013","article-title":"Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF study)","volume":"107","author":"Jiang","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2012.01.062","article-title":"Incidence rates and predictors of major and minor depression in patients with heart failure","volume":"167","author":"Lossnitzer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archpsyc.60.1.24","article-title":"Mineralocorticoid receptor function in major depression","volume":"60","author":"Young","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jchf.2020.06.010_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.psyneuen.2012.09.011","article-title":"Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior","volume":"38","author":"Wu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jchf.2020.06.010_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3758\/s13415-016-0441-4","article-title":"Effects of mineralocorticoid receptor blockade on empathy in patients with major depressive disorder","volume":"16","author":"Wingenfeld","year":"2016","journal-title":"Cogn Affect Behav Neurosci"},{"key":"10.1016\/j.jchf.2020.06.010_bib28","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jamainternmed.2015.5220","article-title":"Cognitive behavior therapy for depression and self-care in heart failure patients a randomized clinical trial","volume":"175","author":"Freedland","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jchf.2020.06.010_bib29","first-page":"465","article-title":"Effects of exercise training on depressive symptoms in patients with chronic heart failure","volume":"308","author":"Trial","year":"2014","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jchf.2020.06.010_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejhf.150","article-title":"Effects of structured heart failure disease management on mortality and morbidity depend on patients\u2019 mood: results from the Interdisciplinary Network for Heart\u00a0Failure study","volume":"16","author":"Gelbrich","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/eurjhf\/hft062","article-title":"How do patients with heart failure with preserved ejection fraction die?","volume":"15","author":"Chan","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jacc.2010.09.031","article-title":"Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure","volume":"57","author":"Sherwood","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.06.010_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCHEARTFAILURE.114.001995","article-title":"Prognostic significance of depression in blacks with heart failure: insights from heart failure: a controlled trial investigating outcomes of exercise training","volume":"8","author":"Mentz","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.06.010_bib34","doi-asserted-by":"crossref","first-page":"1202-7","DOI":"10.1093\/eurjhf\/hfp155","article-title":"Depressive symptoms and outcomes in patients with heart failure: data from the COACH study","volume":"11","author":"Lesman-Leegte","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920303863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920303863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:56:30Z","timestamp":1761972990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177920303863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213177920303863"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2020.06.010","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations Between Depressive Symptoms and HFpEF-Related Outcomes","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}